Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Abbott Vascular; Abiomed; Boston Scientific (Sadra & Claret); Siemens (Corindus Vascular Robotics); Edwards Lifesciences; Cardiovascular Systems Inc (CSI; Wirion System); Gore Medical; Ancora; Medtronic; MitralTech Cardiovalve; Sonivie; TriReme Medical; Cathworks (Triventures); Corvia; Venus Medtech
- Equity/Stock(s)/Options - Arineta, LTD; Conveyor Cardiovascular; Backbeat Medical; Boston Scientific (Sadra & Claret); Caliber Therapeutics; Siemens (Corindus Vascular Robotics); East End Medical LLC; Elixir Medical; Cardiovascular Systems Inc (CSI; Wirion System); Ancora; Hawthorne Effect; Impulse Dynamics; Orbus Neich; Sonivie; V-Wave (TriVentures); Vascular Imaging; Vivasure Medical; Cathworks (TriVentures); K2 Medical LTD; Medinol (Valve Medical)
- Advisory Services Agreement (payment to CUMC)) - Bain Capital
- Advisory Board (no payment) - HeartFlow; K2 Medical LTD; Medinol (Valve Medical); Meril Lifesciences; Abbott Vascular; Arineta, LTD; Conveyor Cardiovascular; Siemens (Corindus Vascular Robotics); East End Medical LLC; Elixir Medical; Hawthorne Effect; MitralTech Cardiovalve; Sonivie; TriReme Medical; Venus Medtech; Medtronic
- Advisory Services Agreement (payment to CUMC) - Heart Leaflet Technologies; Abiomed; Boston Scientific (Sadra & Claret); Gore Medical
- Study Chair (no payment) - Sinomed
- Study Chairman (no payment) - Soundbite LLC; Biosenors LTD; Concept Medical; Cardiac Implants; Ancora
- Principal Investigator (no payment) - SMT (India); Microport; Edwards Lifesciences; Corvia
- Study Advisor (no payment) - Cathworks (TriVentures)